The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 09, 2024

Filed:

Apr. 19, 2022
Applicant:

Arizona Board of Regents on Behalf of the University of Arizona, Tucson, AZ (US);

Inventor:

Jun Wang, Tucson, AZ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 207/273 (2006.01); C07D 207/46 (2006.01); A61K 31/16 (2006.01); A61P 11/00 (2006.01); A61K 9/00 (2006.01); C07D 209/02 (2006.01); A61P 31/14 (2006.01);
U.S. Cl.
CPC ...
C07D 207/273 (2013.01); A61K 9/0014 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 31/16 (2013.01); A61P 11/00 (2018.01); A61P 31/14 (2018.01); C07D 207/46 (2013.01); C07D 209/02 (2013.01);
Abstract

This invention is in the field of medicinal chemistry and relates to a new class of small-molecules having a pyrrolidinone-acetamide (or similar) structure (e.g., Formula I) which function as inhibitors of the SARS-CoV-2 papain-like protease (PL), which function as inhibitors of the SARS-CoV-2 related viral 3CL protease (MP), which function as therapeutics for the treatment of viral infection characterized with PLPand/or Mprotease activity and/or expression (e.g., COVID-19), and which function as therapeutics for the treatment of other conditions characterized with PLPand/or Mprotease activity and/or expression.


Find Patent Forward Citations

Loading…